Candace Carter

ORCID: 0000-0003-4993-1810
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Genomics and Diagnostics
  • Ethics in Clinical Research
  • Biomedical Ethics and Regulation
  • Ferroptosis and cancer prognosis
  • RNA modifications and cancer
  • Cancer-related Molecular Pathways
  • Genetic factors in colorectal cancer
  • Pancreatic and Hepatic Oncology Research
  • Health Systems, Economic Evaluations, Quality of Life
  • RNA Research and Splicing
  • Nitrogen and Sulfur Effects on Brassica
  • Epigenetics and DNA Methylation
  • Ovarian cancer diagnosis and treatment
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Treatments and Mutations
  • Radiomics and Machine Learning in Medical Imaging
  • Endometrial and Cervical Cancer Treatments
  • Chromatin Remodeling and Cancer
  • Bladder and Urothelial Cancer Treatments
  • Glioma Diagnosis and Treatment
  • Mining and Resource Management
  • Genomic variations and chromosomal abnormalities
  • Single-cell and spatial transcriptomics
  • DNA Repair Mechanisms
  • Ancient Mediterranean Archaeology and History

Cooperative Trials Group for Neuro-Oncology
2017-2022

National Health and Medical Research Council
2017-2022

Hudson Institute
2022

Colorado State University
2021-2022

Cargill (United States)
2022

The University of Sydney
2007-2021

New South Wales Department of Health
2017-2021

Duquesne University
2020-2021

National Institute on Deafness and Other Communication Disorders
2018

University of British Columbia
2012-2017

Daniel C. Koboldt Robert S. Fulton Michael D. McLellan Heather K. Schmidt Joelle Kalicki-Veizer and 95 more Joshua F. McMichael Lucinda Fulton David J. Dooling Li Ding Elaine R. Mardis Richard K. Wilson Adrian Ally Miruna Balasundaram Yaron S.N. Butterfield Rebecca Carlsen Candace Carter Andy Chu Eric Chuah Hye Jung E. Chun Robin Coope Noreen Dhalla Ranabir Guin Carrie Hirst Martin Hirst Robert A. Holt Darlene Lee Haiyan I. Li Michael Mayo Richard A. Moore Andrew J. Mungall Erin Pleasance A. Gordon Robertson Jacqueline E. Schein Arash Shafiei Payal Sipahimalani Jared R. Slobodan Dominik Stoll Angela Tam Nina Thiessen Richard Varhol Natasja Wye Thomas Zeng Yongjun Zhao İnanç Birol Steven J.M. Jones Marco A. Marra Andrew D. Cherniack Gordon Saksena Robert C. Onofrio Nam Pho Scott L. Carter Steven E. Schumacher Barbara Tabak Bryan Hernandez Jeff Gentry Huy Nguyen Andrew Crenshaw Kristin Ardlie Rameen Beroukhim Wendy Winckler Gad Getz Stacey Gabriel Matthew Meyerson Lynda Chin Raju Kucherlapati Katherine A. Hoadley J. Todd Auman Huihui Fan Yidi J. Turman Yan Shi Ling Li Michael D. Topal Xiaping He Hann Hsiang Chao Aleix Prat Grace O. Silva Michael D. Iglesia Zhao Wei Jerry Usary Jonathan S. Berg Michael C. C. Adams Jessica K. Booker Junyuan Wu Anisha Gulabani Tom Bodenheimer Alan P. Hoyle Janae V. Simons Matthew G. Soloway Lisle E. Mose Joshua M. Stuart Saianand Balu Peter J. Park D. Neil Hayes Charles M. Perou Simeen Malik Swapna Mahurkar‐Joshi Hui Shen Daniel J. Weisenberger Timothy J. Triche Phillip H. Lai

We analysed primary breast cancers by genomic DNA copy number arrays, methylation, exome sequencing, messenger RNA microRNA sequencing and reverse-phase protein arrays. Our ability to integrate information across platforms provided key insights into previously defined gene expression subtypes demonstrated the existence of four main cancer classes when combining data from five platforms, each which shows significant molecular heterogeneity. Somatic mutations in only three genes (TP53, PIK3CA...

10.1038/nature11412 article EN cc-by-nc-sa Nature 2012-09-21
Gad Getz Stacey B. Gabriel Kristian Cibulskis Eric Lander Andrey Sivachenko and 95 more Carrie Sougnez Robert Lawrence Cyriac Kandoth David J. Dooling Robert W. Fulton Lucinda Fulton Joelle Kalicki-Veizer Michael D. McLellan Michelle D. O’Laughlin Heather K. Schmidt Richard K. Wilson Kai Ye Li Ding Adrian Ally Miruna Balasundaram İnanç Birol Yaron S.N. Butterfield Rebecca Carlsen Candace Carter Andy Chu Eric Chuah Hye Jung E. Chun Noreen Dhalla Ranabir Guin Carrie Hirst Robert A. Holt Steven J.M. Jones Darlene Lee Haiyan I. Li Marco A. Marra Michael Mayo Richard A. Moore Andrew J. Mungall Patrick Plettner Jacqueline E. Schein Payal Sipahimalani Angela Tam Richard Varhol A. Gordon Robertson Andrew D. Cherniack Itai Pashtan Gordon Saksena Robert C. Onofrio Steven E. Schumacher Barbara Tabak Scott L. Carter Bryan Hernandez Jeff Gentry Helga B. Salvesen Kristin Ardlie Wendy Winckler Rameen Beroukhim Matthew Meyerson Angela Hadjipanayis Semin Lee Harshad S. Mahadeshwar Peter J. Park Alexei Protopopov Xiaojia Ren Sahil Seth Xingzhi Song Jiabin Tang Ruibin Xi Lixing Yang Zeng Dong Raju Kucherlapati Lynda Chin Jianhua Zhang J. Todd Auman Saianand Balu Tom Bodenheimer Elizabeth Buda D. Neil Hayes Alan P. Hoyle Joshua M. Stuart Corbin D. Jones Shaowu Meng Piotr A. Mieczkowski Lisle E. Mose Joel S. Parker Charles M. Perou Jeffrey Roach Yan Shi Janae V. Simons Mathew G. Soloway Donghui Tan Michael D. Topal Stephen C. Waring Junyuan Wu Katherine A. Hoadley Stephen B. Baylin Moiz Bootwalla Phillip H. Lai Timothy J. Triche David Van Den Berg

We performed an integrated genomic, transcriptomic and proteomic characterization of 373 endometrial carcinomas using array- sequencing-based technologies. Uterine serous tumours ∼25% high-grade endometrioid had extensive copy number alterations, few DNA methylation changes, low oestrogen receptor/progesterone receptor levels, frequent TP53 mutations. Most alterations or mutations, but mutations in PTEN, CTNNB1, PIK3CA, ARID1A KRAS novel the SWI/SNF chromatin remodelling complex gene ARID5B....

10.1038/nature12113 article EN cc-by-nc-sa Nature 2013-04-30
Rehan Akbani Kadir C. Akdemir Bülent Arman Aksoy Monique Albert Adrian Ally and 95 more Samirkumar B. Amin Harindra Arachchi Arshi Arora J. Todd Auman Brenda Ayala Julien Baboud Miruna Balasundaram Saianand Balu Nandita Barnabas Thomas John Pam Bartlett Boris C. Bastian Stephen B. Baylin Madhusmita Behera D. K. Belyaev Christopher C. Benz Brady Bernard Rameen Beroukhim Natalie Bir Aaron D. Black Tom Bodenheimer Lori Boice Genevieve M. Boland R. Bono Moiz Bootwalla Marcus Bosenberg Jay Bowen Reanne Bowlby Christopher A. Bristow Laura Brockway-Lunardi Denise Brooks Jakub Brzezinski Wiam Bshara Elizabeth Buda William R. Burns Yaron S.N. Butterfield M. Button Tiffany L. Calderone Giancarlo Antonini Cappellini Candace Carter Scott L. Carter Lynn Cherney Andrew D. Cherniack Aaron Chevalier Lynda Chin Juok Cho Raymond J. Cho Yoon‐La Choi Andy Chu Sudha Chudamani Kristian Cibulskis Giovanni Ciriello Amanda Clarke Stephen W. Coons Leslie Cope Daniel Crain Erin Curley Ludmila Danilova Stefania D’Atri Tanja M. Davidsen Michael A. Davies Keith A. Delman John A. Demchok Qing Deng Yonathan Lissanu Deribe Noreen Dhalla Rajiv Dhir Daniel DiCara М С Диникин Michael Dubina J. Stephen Ebrom Sophie Egea Greg Eley Jay Engel Jennifer Eschbacher Konstantin Fedosenko Ina Felau Timothy R. Fennell Martin L. Ferguson Sheila Fisher Keith T. Flaherty Scott Frazer Jessica Frick Victoria Fulidou Stacey Gabriel Jianjiong Gao Johanna Gardner Levi A. Garraway Julie M. Gastier-Foster Carmelo Gaudioso Nils Gehlenborg Giannicola Genovese Mark Gerken Hui Shen Gad Getz

10.1016/j.cell.2015.05.044 article EN publisher-specific-oa Cell 2015-06-01

Each year funding agencies and academic institutions spend millions of dollars euros on biobanking. All providers assume that after initial investments biobanks should be able to operate sustainably. However the topic sustainability is challenging for discipline biobanking several major reasons: diversity in landscape, different purposes biobanks, fact are dissimilar other research infrastructures absence universally understood or applicable value metrics funders stakeholders. In this...

10.1089/bio.2013.0064 article EN Biopreservation and Biobanking 2014-02-01

Biobanks face increasing demands for research materials of consistent quality, which can be used in collaborative studies. Several countries and some international agencies have made formal efforts to standardize biobank operations outputs. These include the establishment best practice guidelines collection management, certification programs. Such programs increase biobanks' opportunities participation high impact funding. However, they also impose economic time costs, may burden biobanks....

10.1089/bio.2017.0095 article EN Biopreservation and Biobanking 2017-12-07

Vanilloids including capsaicin and resiniferatoxin (RTX) have been identified as potential novel anti-inflammatory analgesic compounds. We previously shown that systemic administration to neonatal rats evokes profound long-term alterations in transient receptor vanilloid 1 (TRPV1)- neurokinin (NK<sub>1</sub>) receptor-mediated respiratory responses the commissural nucleus of solitary tract (cNTS). Whether this effect is unique developmentally immature animals unknown. Therefore,...

10.1159/000324530 article EN Pharmacology 2011-01-01

Biobanks are resources that facilitate research. Many biobanks exist around the world, but most tend to focus on a specific disease or research area. BC Children's Hospital and Women's located same campus (Oak Street Campus) in Vancouver, BC, Canada. A campus-wide biobank has been established site of these two hospitals collect specimens annotated data from children women seeking medical care at either hospitals. Such an initiative requires careful planning consideration many factors such as...

10.1089/bio.2016.0077 article EN Biopreservation and Biobanking 2017-02-01

Human health biobanks are forms of research infrastructure that supply biospecimens and associated data to researchers, therefore juxtapose the activities clinical care biomedical research. The discipline biobanking has existed for over 20 years is supported by several international professional societies dedicated academic journals. However, despite both rising demand human biospecimens, growth as an discipline, many individual continue experience sustainability challenges. This commentary...

10.1177/11772719211024100 article EN cc-by-nc Biomarker Insights 2021-01-01

Glioblastoma (GBM) is the most common malignant primary central nervous system cancer in adults. The objective of Multi-Arm GlioblastoMa Australasia (MAGMA) trial to test hypotheses real world setting improve survival people with GBM. Initial experimental arms are evaluating effectiveness interventions newly diagnosed GBM (ndGBM). This study will compare maximal surgical resection followed by chemoradiotherapy plus adjuvant chemotherapy for 6 months addition (1) 'neoadjuvant' beginning as...

10.1136/bmjopen-2021-058107 article EN cc-by-nc BMJ Open 2022-09-01

The neuro-oncology community in Australia is well positioned to collaborate internationally, with a motivated trials group, strong regulatory bodies and an attractive fiscal environment. We sought identify gaps the Australian clinical landscape describe strategies increase international trial access Australia.We searched registries active adult primary brain cancer trials. compared participation rate phase of these between tumour types countries. A survey was distributed Cooperative Trials...

10.1111/ajco.13606 article EN cc-by-nc-nd Asia-Pacific Journal of Clinical Oncology 2021-06-24

The small marble group in the collection of antiquities New York University, published by Karl Lehmann as "The Girl Beneath Apple Tree" AJA 49 (1945) 430-33, can now be reinterpreted. A comparison with a coin from Temenothyrae (Phrygia) time Valerian allows us to reconstruct representation Herakles Garden Hesperides, and restore figure on right side base, empty. statuette is thus "promoted" genre scene mythological representation. Ganymede Eagle excavated at Carthage 1977, recently Elaine...

10.2307/505219 article EN American Journal of Archaeology 1987-04-01
Coming Soon ...